Literature DB >> 20726789

Postinfluenza bacterial pneumonia: host defenses gone awry.

Megan N Ballinger1, Theodore J Standiford.   

Abstract

Influenza is a common respiratory pathogen causing both seasonal and pandemic disease. Influenza infection predisposes the host to secondary bacterial infection of the respiratory tract, which is a major cause of both morbidity and mortality in flu-related disease. In this review, we will discuss innate and adaptive antiviral responses during influenza infection, and review how these responses modulate protective immunity against secondary bacterial pathogens of the lung. Specific emphasis will be placed on implications of bacterial superinfection and mechanisms involved.

Entities:  

Mesh:

Year:  2010        PMID: 20726789      PMCID: PMC4367524          DOI: 10.1089/jir.2010.0049

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  68 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

2.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

3.  2009 pandemic H1N1 influenza virus replicates in human lung tissues.

Authors:  Jinxia Zhang; Zengfeng Zhang; Xiaohui Fan; Yuansheng Liu; Jia Wang; Zuoyi Zheng; Rirong Chen; Pui Wang; Wenjun Song; Honglin Chen; Yi Guan
Journal:  J Infect Dis       Date:  2010-05-15       Impact factor: 5.226

4.  Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection.

Authors:  Lynnelle A McNamee; Allen G Harmsen
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

5.  Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung.

Authors:  Cherrie-Lee Small; Christopher R Shaler; Sarah McCormick; Mangalakumari Jeyanathan; Daniela Damjanovic; Earl G Brown; Petra Arck; Manel Jordana; Charu Kaushic; Ali A Ashkar; Zhou Xing
Journal:  J Immunol       Date:  2010-01-18       Impact factor: 5.422

6.  Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.

Authors:  Jonathan A McCullers; Jerold E Rehg
Journal:  J Infect Dis       Date:  2002-07-10       Impact factor: 5.226

Review 7.  Innate immune control and regulation of influenza virus infections.

Authors:  Jodi McGill; Jonathan W Heusel; Kevin L Legge
Journal:  J Leukoc Biol       Date:  2009-07-30       Impact factor: 4.962

8.  Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.

Authors:  Seema Jain; Laurie Kamimoto; Anna M Bramley; Ann M Schmitz; Stephen R Benoit; Janice Louie; David E Sugerman; Jean K Druckenmiller; Kathleen A Ritger; Rashmi Chugh; Supriya Jasuja; Meredith Deutscher; Sanny Chen; John D Walker; Jeffrey S Duchin; Susan Lett; Susan Soliva; Eden V Wells; David Swerdlow; Timothy M Uyeki; Anthony E Fiore; Sonja J Olsen; Alicia M Fry; Carolyn B Bridges; Lyn Finelli
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

9.  Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae.

Authors:  Lynnelle A Pittet; Luanne Hall-Stoodley; Melanie R Rutkowski; Allen G Harmsen
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-11       Impact factor: 6.914

10.  Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.

Authors:  Yumiko Imai; Keiji Kuba; G Greg Neely; Rubina Yaghubian-Malhami; Thomas Perkmann; Geert van Loo; Maria Ermolaeva; Ruud Veldhuizen; Y H Connie Leung; Hongliang Wang; Haolin Liu; Yang Sun; Manolis Pasparakis; Manfred Kopf; Christin Mech; Sina Bavari; J S Malik Peiris; Arthur S Slutsky; Shizuo Akira; Malin Hultqvist; Rikard Holmdahl; John Nicholls; Chengyu Jiang; Christoph J Binder; Josef M Penninger
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

View more
  49 in total

1.  Statins and influenza: can we move forward?

Authors:  Edward E Walsh
Journal:  J Infect Dis       Date:  2011-12-13       Impact factor: 5.226

2.  Regulation of innate CD8+ T-cell activation mediated by cytokines.

Authors:  Bailey E Freeman; Erika Hammarlund; Hans-Peter Raué; Mark K Slifka
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

3.  Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice.

Authors:  Benjamin Lee; Keven M Robinson; Kevin J McHugh; Erich V Scheller; Sivanarayana Mandalapu; Chen Chen; Y Peter Di; Michelle E Clay; Richard I Enelow; Patricia J Dubin; John F Alcorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-05-22       Impact factor: 5.464

4.  Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation.

Authors:  Ezgi Demirdogen Cetinoglu; Esra Uzaslan; Abdullah Sayıner; Aykut Cilli; Oguz Kılınc; Aysın Sakar Coskun; Armağan Hazar; Nurdan Kokturk; Ayten Filiz; Mehmet Polatli
Journal:  Hum Vaccin Immunother       Date:  2017-07-14       Impact factor: 3.452

5.  Why is coinfection with influenza virus and bacteria so difficult to control?

Authors:  Linda S Cauley; Anthony T Vella
Journal:  Discov Med       Date:  2015-01       Impact factor: 2.970

Review 6.  Effects of influenza immunization on pneumonia in the elderly.

Authors:  Jung Yeon Heo; Joon Young Song; Ji Yun Noh; Min Joo Choi; Jin Gu Yoon; Saem Na Lee; Hee Jin Cheong; Woo Joo Kim
Journal:  Hum Vaccin Immunother       Date:  2017-12-19       Impact factor: 3.452

7.  Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults in the era of highly active antiretroviral therapy: analysis stratified by CD4 T-cell count.

Authors:  Joon Young Song; Hee Jin Cheong; Ji Yun Noh; Min Joo Choi; Jin Gu Yoon; Woo Joo Kim
Journal:  Hum Vaccin Immunother       Date:  2019-08-23       Impact factor: 3.452

8.  Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenza.

Authors:  Wilbur H Chen; Franklin R Toapanta; Kari Ann Shirey; Lei Zhang; Angeliki Giannelou; Carly Page; Matthew B Frieman; Stefanie N Vogel; Alan S Cross
Journal:  Immunol Lett       Date:  2011-10-20       Impact factor: 3.685

9.  Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infection.

Authors:  Katia E Garcia-Crespo; Calvin C Chan; Stanislaw J Gabryszewski; Caroline M Percopo; Peter Rigaux; Kimberly D Dyer; Joseph B Domachowske; Helene F Rosenberg
Journal:  Antiviral Res       Date:  2012-12-26       Impact factor: 5.970

10.  Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.

Authors:  Stoyan Ivanov; Joelle Renneson; Josette Fontaine; Adeline Barthelemy; Christophe Paget; Elodie Macho Fernandez; Fany Blanc; Carl De Trez; Laurye Van Maele; Laure Dumoutier; Michel-René Huerre; Gérard Eberl; Mustapha Si-Tahar; Pierre Gosset; Jean Christophe Renauld; Jean Claude Sirard; Christelle Faveeuw; François Trottein
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.